Molecules/SPESOLIMAB

SPESOLIMAB

Molecular Identity

AntibodyApprovedFirst approved 2022

Mechanism of action: IL36 receptor antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

BI 655130BI-655130BI655130ESPESOLIMABSPESOLIMABSPESOLIMAB SBZOSPESOLIMAB-SBZOSpevigo

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to SPESOLIMAB

Loading drug network...